Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients

Journal of Hypertension

Volumn 27, Issue 3, 2009, Pages 613-617

  Perticone, Francesco ^a,b   Maio, Raffaele ^a   Sciacqua, Angela ^a   Perticone, Maria ^a   Laino, Irma ^a   Miceli, Sofia ^a   Mazzaferro, Debora ^a   Pascale, Alessandra ^a   Andreozzi, Francesco ^a   Sesti, Giorgio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Campus Universitario Salvatore Venuta di Germaneto ^*  (Italy)

Author keywords

Hypertension; Insulin resistance; Insulin like growth factor 1; Renal function

Indexed keywords

CREATININE; GLUCOSE; INSULIN; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 67649518815     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32831fda24     Document Type: Article

References (25)

1. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16:3-34.
2. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, et al. Insulin-like growth factor 1 receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986; 5:2503-2512.
3. DingH, Gao XL, Hirschberg R,Vadgama JV, KoppleJD. Impaired actions of insulin-like growth factor 1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect. J Clin Invest 1996; 97:1064-1075.
4. Baumann U, Eisenhauer T, Hartmann H. Increase of glomerular filtration rate and renal plasma flow by insulin-like growth factor-1 during euglycaemic clamping in anaesthetized rats. Eur J Clin Invest 1992; 22:204-209.
5. Guler HP, Zapf J, Scheiwiller E, Froesch ER. Recombinant human insulinlike growth factor 1 stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988; 85:4889-4893.
6. Miller SB, Martin DR, Kissane J, Hammerman MR. Insulin-like growth factor 1 accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 1992; 89:11876-11880.
7. Vijayan A, Franklin SC, Behrend T, Hammerman MR, Miller SB. Insulin-like growth factor 1 improves renal function in patients with end-stage chronic renal failure. Am J Physiol 1999; 276:R929-R934.
8. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention: kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 2003; 42:1050-1065.
9. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116:85-97.
10. Schillaci G, Reboldi G, Verdecchia P. High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med 2001; 161:886-891.
11. Neuringer JR, Brenner BM. Hemodynamic theory of progressive renal disease: a 10-year update in brief review. Am J Kidney Dis 1993; 104:98-104.
12. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
13. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334:374-381.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and *-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
16. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
17. Dullaart RP, Meijer S, Marbach P, Sluiter WJ. Effect of a somatostatin analogue, octreotide, on renal haemodynamics and albuminuria in acromegalic patients. Eur J Clin Invest 1992; 22:494-502.
18. Shultz PJ, Schorer AE, Raij L. Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am J Physiol 1990; 258:F162-F167.
19. Haylor J, Singh I, el Nahas AM. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. Kidney Int 1991; 39:333-335.
20. G-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF-1. J Clin Invest 1996; 97:1319-1328.
21. Bidani AK, Griffin KA. Patophysiology of hypertensive renal damage. Implications for therapy. Hypertension 2004; 44:595-601.
22. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998; 53:1343-1347.
23. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24:816-823.
24. Perticone F, Maio R, Tripepi G, Zoccali C. Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 2004; 110:821-825.
25. Sesti G, Sciacqua A, Cardellini M, Marini MA, Maio R, Vatrano M, et al. Plasma concentration of IGF-1 is independently associated with insulin sensitivity in subjects with different degreees of glucose tolerance. Diabetes Care 2005; 28:120-125.